CARL ZEISS MEDITEC AG - BR (1AFX.MI) Fundamental Analysis & Valuation

BIT:1AFX • DE0005313704

Current stock price

25.42 EUR
+0.98 (+4.01%)
Last:

This 1AFX.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. 1AFX.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1AFX was profitable.
  • 1AFX had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1AFX has been profitable.
  • Each year in the past 5 years 1AFX had a positive operating cash flow.
1AFX.MI Yearly Net Income VS EBIT VS OCF VS FCF1AFX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • 1AFX has a better Return On Assets (4.15%) than 61.90% of its industry peers.
  • With a Return On Equity value of 6.67%, 1AFX perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
  • 1AFX has a Return On Invested Capital (5.79%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1AFX is below the industry average of 10.21%.
Industry RankSector Rank
ROA 4.15%
ROE 6.67%
ROIC 5.79%
ROA(3y)6.33%
ROA(5y)7.85%
ROE(3y)9.62%
ROE(5y)11.54%
ROIC(3y)7.11%
ROIC(5y)9.66%
1AFX.MI Yearly ROA, ROE, ROIC1AFX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

  • With a Profit Margin value of 6.34%, 1AFX perfoms like the industry average, outperforming 53.97% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1AFX has declined.
  • Looking at the Operating Margin, with a value of 10.03%, 1AFX is in line with its industry, outperforming 47.62% of the companies in the same industry.
  • 1AFX's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 52.76%, 1AFX is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of 1AFX has remained more or less at the same level.
Industry RankSector Rank
OM 10.03%
PM (TTM) 6.34%
GM 52.76%
OM growth 3Y-21.67%
OM growth 5Y-5.49%
PM growth 3Y-25.69%
PM growth 5Y-7.11%
GM growth 3Y-3.8%
GM growth 5Y-1.12%
1AFX.MI Yearly Profit, Operating, Gross Margins1AFX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. 1AFX.MI Health Analysis

2.1 Basic Checks

  • 1AFX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • 1AFX has about the same amout of shares outstanding than it did 1 year ago.
  • 1AFX has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1AFX has an improved debt to assets ratio.
1AFX.MI Yearly Shares Outstanding1AFX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
1AFX.MI Yearly Total Debt VS Total Assets1AFX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • 1AFX has an Altman-Z score of 2.78. This is not the best score and indicates that 1AFX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.78, 1AFX perfoms like the industry average, outperforming 58.73% of the companies in the same industry.
  • The Debt to FCF ratio of 1AFX is 4.41, which is a neutral value as it means it would take 1AFX, 4.41 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of 1AFX (4.41) is better than 61.90% of its industry peers.
  • 1AFX has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • 1AFX has a better Debt to Equity ratio (0.27) than 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 4.41
Altman-Z 2.78
ROIC/WACC0.89
WACC6.53%
1AFX.MI Yearly LT Debt VS Equity VS FCF1AFX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.35 indicates that 1AFX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.35, 1AFX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • 1AFX has a Quick Ratio of 1.44. This is a normal value and indicates that 1AFX is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of 1AFX (1.44) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 1.44
1AFX.MI Yearly Current Assets VS Current Liabilites1AFX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1AFX.MI Growth Analysis

3.1 Past

  • 1AFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.51%.
  • The Earnings Per Share has been growing slightly by 3.32% on average over the past years.
  • 1AFX shows a small growth in Revenue. In the last year, the Revenue has grown by 5.89%.
  • The Revenue has been growing by 10.78% on average over the past years. This is quite good.
EPS 1Y (TTM)-17.51%
EPS 3Y-21.2%
EPS 5Y3.32%
EPS Q2Q%-83.33%
Revenue 1Y (TTM)5.89%
Revenue growth 3Y5.39%
Revenue growth 5Y10.78%
Sales Q2Q%-4.79%

3.2 Future

  • 1AFX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.94% yearly.
  • The Revenue is expected to grow by 5.17% on average over the next years.
EPS Next Y1.24%
EPS Next 2Y12.96%
EPS Next 3Y14.01%
EPS Next 5Y14.94%
Revenue Next Year2.21%
Revenue Next 2Y3.76%
Revenue Next 3Y4.34%
Revenue Next 5Y5.17%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1AFX.MI Yearly Revenue VS Estimates1AFX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
1AFX.MI Yearly EPS VS Estimates1AFX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. 1AFX.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.41, the valuation of 1AFX can be described as rather expensive.
  • Based on the Price/Earnings ratio, 1AFX is valued cheaply inside the industry as 82.54% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of 1AFX to the average of the S&P500 Index (26.78), we can say 1AFX is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 12.37, 1AFX is valued correctly.
  • Based on the Price/Forward Earnings ratio, 1AFX is valued cheaply inside the industry as 84.13% of the companies are valued more expensively.
  • 1AFX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.41
Fwd PE 12.37
1AFX.MI Price Earnings VS Forward Price Earnings1AFX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1AFX indicates a rather cheap valuation: 1AFX is cheaper than 85.71% of the companies listed in the same industry.
  • 1AFX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1AFX is cheaper than 82.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.06
EV/EBITDA 7.58
1AFX.MI Per share data1AFX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as 1AFX's earnings are expected to grow with 14.01% in the coming years.
PEG (NY)14
PEG (5Y)5.24
EPS Next 2Y12.96%
EPS Next 3Y14.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. 1AFX.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.33%, 1AFX has a reasonable but not impressive dividend return.
  • 1AFX's Dividend Yield is a higher than the industry average which is at 1.20.
  • 1AFX's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.33%

5.2 History

  • The dividend of 1AFX decreases each year by -1.59%.
Dividend Growth(5Y)-1.59%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1AFX pays out 37.19% of its income as dividend. This is a sustainable payout ratio.
DP37.19%
EPS Next 2Y12.96%
EPS Next 3Y14.01%
1AFX.MI Yearly Income VS Free CF VS Dividend1AFX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M
1AFX.MI Dividend Payout.1AFX.MI Dividend Payout, showing the Payout Ratio.1AFX.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1AFX.MI Fundamentals: All Metrics, Ratios and Statistics

CARL ZEISS MEDITEC AG - BR

BIT:1AFX (4/9/2026, 7:00:00 PM)

25.42

+0.98 (+4.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)05-11
Inst Owners24.4%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.27B
Revenue(TTM)2.20B
Net Income(TTM)141.22M
Analysts66.09
Price Target37.65 (48.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.33%
Yearly Dividend0.6
Dividend Growth(5Y)-1.59%
DP37.19%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.46%
Min EPS beat(2)-33.88%
Max EPS beat(2)-9.05%
EPS beat(4)1
Avg EPS beat(4)-16.59%
Min EPS beat(4)-36.67%
Max EPS beat(4)13.25%
EPS beat(8)4
Avg EPS beat(8)-3.62%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.89%
Min Revenue beat(2)-1.14%
Max Revenue beat(2)2.92%
Revenue beat(4)3
Avg Revenue beat(4)1.59%
Min Revenue beat(4)-1.14%
Max Revenue beat(4)3.76%
Revenue beat(8)5
Avg Revenue beat(8)-0.32%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.25%
PT rev (3m)-32.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-15.87%
EPS NY rev (3m)-24.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.94%
Revenue NY rev (3m)-2.74%
Valuation
Industry RankSector Rank
PE 17.41
Fwd PE 12.37
P/S 1.02
P/FCF 17.06
P/OCF 10.83
P/B 1.07
P/tB 4.7
EV/EBITDA 7.58
EPS(TTM)1.46
EY5.74%
EPS(NY)2.05
Fwd EY8.08%
FCF(TTM)1.49
FCFY5.86%
OCF(TTM)2.35
OCFY9.23%
SpS24.91
BVpS23.66
TBVpS5.41
PEG (NY)14
PEG (5Y)5.24
Graham Number27.88
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 6.67%
ROCE 7.81%
ROIC 5.79%
ROICexc 5.89%
ROICexgc 14.08%
OM 10.03%
PM (TTM) 6.34%
GM 52.76%
FCFM 5.98%
ROA(3y)6.33%
ROA(5y)7.85%
ROE(3y)9.62%
ROE(5y)11.54%
ROIC(3y)7.11%
ROIC(5y)9.66%
ROICexc(3y)7.22%
ROICexc(5y)9.75%
ROICexgc(3y)13.97%
ROICexgc(5y)15.82%
ROCE(3y)9.59%
ROCE(5y)13.04%
ROICexgc growth 3Y-8.4%
ROICexgc growth 5Y5.81%
ROICexc growth 3Y-23.03%
ROICexc growth 5Y-5.18%
OM growth 3Y-21.67%
OM growth 5Y-5.49%
PM growth 3Y-25.69%
PM growth 5Y-7.11%
GM growth 3Y-3.8%
GM growth 5Y-1.12%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 4.41
Debt/EBITDA 1.61
Cap/Depr 60.61%
Cap/Sales 3.44%
Interest Coverage 10.38
Cash Conversion 60%
Profit Quality 94.37%
Current Ratio 2.35
Quick Ratio 1.44
Altman-Z 2.78
F-Score6
WACC6.53%
ROIC/WACC0.89
Cap/Depr(3y)109.66%
Cap/Depr(5y)110.76%
Cap/Sales(3y)5.42%
Cap/Sales(5y)4.92%
Profit Quality(3y)64.92%
Profit Quality(5y)71.29%
High Growth Momentum
Growth
EPS 1Y (TTM)-17.51%
EPS 3Y-21.2%
EPS 5Y3.32%
EPS Q2Q%-83.33%
EPS Next Y1.24%
EPS Next 2Y12.96%
EPS Next 3Y14.01%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.89%
Revenue growth 3Y5.39%
Revenue growth 5Y10.78%
Sales Q2Q%-4.79%
Revenue Next Year2.21%
Revenue Next 2Y3.76%
Revenue Next 3Y4.34%
Revenue Next 5Y5.17%
EBIT growth 1Y14.86%
EBIT growth 3Y-17.44%
EBIT growth 5Y4.69%
EBIT Next Year51.32%
EBIT Next 3Y23.17%
EBIT Next 5Y16.25%
FCF growth 1Y40.11%
FCF growth 3Y7.85%
FCF growth 5Y-0.04%
OCF growth 1Y-15.15%
OCF growth 3Y3.7%
OCF growth 5Y3.29%

CARL ZEISS MEDITEC AG - BR / 1AFX.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CARL ZEISS MEDITEC AG - BR (1AFX.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1AFX.MI.


What is the valuation status for 1AFX stock?

ChartMill assigns a valuation rating of 8 / 10 to CARL ZEISS MEDITEC AG - BR (1AFX.MI). This can be considered as Undervalued.


Can you provide the profitability details for CARL ZEISS MEDITEC AG - BR?

CARL ZEISS MEDITEC AG - BR (1AFX.MI) has a profitability rating of 4 / 10.


What is the valuation of CARL ZEISS MEDITEC AG - BR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CARL ZEISS MEDITEC AG - BR (1AFX.MI) is 17.41 and the Price/Book (PB) ratio is 1.07.


Is the dividend of CARL ZEISS MEDITEC AG - BR sustainable?

The dividend rating of CARL ZEISS MEDITEC AG - BR (1AFX.MI) is 4 / 10 and the dividend payout ratio is 37.19%.